查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1449641

全球供应商中立存檔 (VNA) 市场：按部署模型、按供应商类型、按映像类型、按最终用户、按区域。

Global Vendor Neutral Archive Market, By Deployment Model, By Vendor Type (Independent Software Vendors, PACS Vendors, Infrastructure Vendors), By Imaging Type, By End User, By Geography .
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球供应商中立存檔（VNA）市场价值将达到39.6亿美元，预计到2031年将达到59.3亿美元，2024年至2031年的复合年增长率为5.2%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 39.6亿美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024~2030/2031年复合成长率： 5.20% 2030/2031 年预测值 59.3亿美元
图 1. 2023 年供应商中立檔案 (VNA) 按地区分類的全球市场占有率(%)
全球供应商中立存檔市场-IMG1

供应商中立存檔 (VNA) 是一种影像管理解决方案，可让任何医疗保健应用程式从多个来源和方式储存、查询和搜寻医疗图像和相关报告。传统上，医疗保健组织必须管理多个 PACS 系统来储存和存取放射影像，从而增加了成本和技术复杂性。 VNA 提供了一个中央储存库，将所有部门、资讯来源和专业的影像资料整合到一个檔案中。这促进了互通性、普遍可近性和优化的护理协调。

市场动态：

供应商中立檔案（VNA）市场的成长是由于慢性病的流行而导致的影像处理量的增加、对医疗影像集中储存系统的偏好以及各种医疗保健中资料共用的改进和患者照护协调的加强所推动的交付环境等因素驱动。然而，安装和维护 VNA 的高昂成本以及缺乏专业知识（尤其是在小型医疗机构中）限制了其广泛普及。同时，远端医疗实践的扩展、支援人工智慧整合的技术进步以及预测分析为供应商提供了利润丰厚的机会。

本研究的主要特点

  • 该研究报告详细分析了全球供应商中立存檔 (VNA) 市场，并提供了以 2022 年为基准年的预测期 (2024-2031) 的市场规模和年复合成长率(CAGR%)。
  • 它还说明了各个细分市场的潜在收益成长机会，并为该市场提供了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 该报告根据公司亮点、产品系列、主要成就、财务表现和策略等参数，介绍了全球供应商中立檔案 (VNA) 市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球供应商中立檔案 (VNA) 市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球供应商中立檔案（VNA）市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 服务交付组合
  • PEST分析
  • 波特的分析
  • 併购场景
  • 管道分析

第四章全球供应商中立檔案（VNA）市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第 5 章 2019-2031 年全球供应商中立存檔 (VNA) 市场（依部署模式）

  • 本地 VNA
  • 云端基础的VNA

第 6 章 全球供应商中立存檔 (VNA) 市场，依供应商类型，2019-2031 年

  • 独立软体供应商 (ISV)
  • PACS供应商
  • 基础设施供应商

第 7 章 2019-2031 年全球供应商中立存檔 (VNA) 市场（依影像类型）

  • 放射学 VNA
  • 心臟病学 VNA
  • 病理学

第 8 章 全球供应商中立存檔 (VNA) 市场，依最终用户划分，2019-2031 年

  • 医院
  • 影像诊断中心
  • 门诊治疗中心
  • 研究和学术机构

第 9 章全球供应商中立存檔 (VNA) 市场，按地区划分，2019-2031 年

  • 北美洲
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争格局

  • Johnson & Johnson Private Limited
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Baxter
  • Bayer AG
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • Allergan
  • AbbVie Inc.
  • Abbott
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6654

The global vendor neutral archive (VNA) market was valued US$ 3.96 Bn in 2023 and is expected to reach US$ 5.93 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 3.96 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 5.20% 2030/2031 Value Projection: US$ 5.93 Bn
Figure 1. Global Vendor Neutral Archive (VNA) Market Share (%), By Region, 2023
Global Vendor Neutral Archive Market - IMG1

Vendor neutral archive (VNA) is an image management solution that allows medical images and associated reports to be stored, queried, and retrieved by any healthcare application from multiple sources and modalities. Traditionally, healthcare organizations have had to manage multiple PACS systems to store and access radiology images which led to increased costs and technological complexities. A VNA provides a central repository that consolidates imaging data from all departments, sources, and specialties in a single archive. This facilitates interoperability, universal access, and optimized care collaboration.

Market Dynamics:

The growth of the vendor neutral archive (VNA) market is driven by factors such as rising imaging volumes due to increasing prevalence of chronic diseases, growing preferences for centralized medical imaging storage systems, and need to improve data sharing and enhance patient care coordination across various care delivery settings. However, high costs associated with the deployment and maintenance of VNAs as well as lack of expertise especially in small healthcare facilities limit their widespread adoption. Meanwhile, growing telehealth practices, technological advancements to enable artificial intelligence integration, and predictive analytics present lucrative opportunities for vendors.

Key features of the study:

  • This report provides an in-depth analysis of the global vendor neutral archive (VNA) market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global vendor neutral archive (VNA) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, and AstraZeneca
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global vendor neutral archive (VNA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vendor neutral archive (VNA) market

Detailed Segmentation:

  • Global Vendor Neutral Archive (VNA) Market, By Deployment Model
    • On-Premise VNA
    • Cloud-Based VNA
  • Global Vendor Neutral Archive (VNA) Market, By Vendor Type
    • Independent Software Vendors (ISVs)
    • PACS Vendors
    • Infrastructure Vendors
  • Global Vendor Neutral Archive (VNA) Market, By Imaging Type
    • Radiology VNAs
    • Cardiology VNAs
    • Pathology VNAs
  • Global Vendor Neutral Archive (VNA) Market, By End-User
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Care Centers
    • Research and Academic Institutes
  • Global Vendor Neutral Archive (VNA) Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Global Vendor Neutral Archive (VNA) Market, Key Players
    • Johnson & Johnson Private Limited
    • Merck & Co., Inc.
    • F.Hoffmann-La Roche Ltd.
    • Baxter
    • Bayer AG
    • Eli Lilly and Company
    • Sun Pharmaceutical Industries Ltd.
    • Aurobindo Pharma
    • Lupin
    • Allergan
    • AbbVie Inc.
    • Abbott
    • Bausch Health Companies Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • AstraZeneca

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Vendor Neutral Archive (VNA) Market, By Deployment Model
    • Global Vendor Neutral Archive (VNA) Market, By Vendor Type
    • Global Vendor Neutral Archive (VNA) Market, By Imaging Type
    • Global Vendor Neutral Archive (VNA) Market, By End User
    • Global Vendor Neutral Archive (VNA) Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing adoption of cloud-based VNA solutions
    • Growing adoption of imaging equipment across healthcare facilities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service Offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Vendor Neutral Archive (VNA) Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • On-premise VNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Cloud-based VNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Independent Software Vendors (ISVs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • PACS Vendors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Infrastructure Vendors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Radiology VNAs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Cardiology VNAs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Pathology VNAs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Vendor Neutral Archive (VNA) Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Diagnostic Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Vendor Neutral Archive (VNA) Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Johnson & Johnson Private Limited
    • Company Highlights
    • Deployment Model Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Deployment Model Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Deployment Model Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Baxter
    • Company Highlights
    • Deployment Model Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bayer AG
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • Allergan
  • AbbVie Inc.
  • Abbott
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca
  • Analyst Views

11. Section

  • Research Methodology
  • About us